Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder.

Yves DauvilliersGary ZammitIngo FietzeDavid MaylebenDalma Seboek KinterScott PainJan Hedner

Published in: Annals of neurology (2020)

Daridorexant induced a dose-dependent reduction in wake time after sleep onset in subjects with insomnia disorder (Clinicaltrials.gov NCT02839200). Ann Neurol 2020;87:347-356.

Keyphrases

sleep quality
high glucose
diabetic rats
physical activity
depressive symptoms
oxidative stress